Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
395.00Today’s High
410.0052W low
280.0052W High
425.20Open Price
400.00Prev. Close
360.8000Volume
802408.00Value
320321273.60Fundamentals
Market Cap
4464.00
Price to Earnings
33.50
Price to Book Value
3.30
Dividend Yield
1.30
PE to Growth
1.30
Op Revenue TTM
623.87
Net Profit TTM
133.30
Cash From Operating Activity
141.37
Return on Equity %
10.06
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
43
Week
45.6
Month
49.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
401.42
PIVOT
First Resistance
407.78
Second Resistance
416.37
Third Resistance
422.73
First Support
392.83
Second Support
386.47
Third Support
377.88
Relative Strength Index
61.18
Money Flow Index
65.26
MACD
4.02
MACD Signal
2.13
Average True Range
14.8
Average Directional Index
20.83
Rate of Change (21)
13.25
Rate of Change (125)
6.02
Commodity Channel Index
152.8
Williams %R
-24
BETA
1 Month
0.08
3 Month
0.5
1 Year
0.45
3 Year
0.2
PRICE CHANGE ANALYSIS
↑ 4.57%
1 Week
Low
High
367.2
410
↑ 10.64%
1 Month
Low
High
358
410
↑ 10.97%
3 Months
Low
High
334.05
410
↑ 6.16%
6 Months
Low
High
334.05
425.15
↑ 37.18%
1 Year
Low
High
280
425.15
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 95.61 | 94.71 | 97.36 | 136.60 | 85.37 | 83.44 | 79.18 | 73.36 | 75.92 | 65.45 | 66.81 | |
| Operating Expenses Qtr | 63.16 | 66.59 | 69.96 | 60.57 | 59.28 | 58.49 | 58.23 | 60.64 | 55.37 | 51.18 | 47.27 | |
| Operating Profit Qtr | 29.24 | 24.55 | 26.62 | 24.78 | 23.28 | 21.19 | 18.95 | 11.47 | 15.38 | 13.20 | 17.64 | |
| EBIDT Qtr Cr | 13.51 | 28.11 | 27.40 | 76.03 | 26.09 | 24.95 | 20.95 | 12.71 | 20.55 | 14.27 | 19.54 | |
| Depreciation Qtr | 3.07 | 2.71 | 2.61 | 2.51 | 2.76 | 2.61 | 2.51 | 2.41 | 2.53 | 2.47 | 2.29 | |
| Net Profit Qtr | 3.14 | 19.12 | 18.38 | 67.49 | 17.50 | 16.64 | 13.62 | 7.78 | 14.35 | 8.77 | 12.84 | |
| Basic EPS Qtr | 0.28 | 1.71 | 1.64 | 6.04 | 1.56 | 1.49 | 1.22 | 0.70 | 1.28 | 0.78 | 1.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 424.28 | 321.34 | 281.88 | 290.30 | 256.36 | |
| Operating Expenses Annual Cr | 260.28 | 236.64 | 200.15 | 182.85 | 170.59 | |
| Operating Profit Annual | 105.19 | 74.89 | 72.65 | 100.62 | 76.77 | |
| Operating Profit Margin Annual % | 24.79 | 23.31 | 25.77 | 34.66 | 29.95 | |
| Total Expenses Annual Cr | 271.34 | 247.06 | 209.81 | 191.87 | 180.50 | |
| EBIDT Annual Cr | 164.00 | 84.70 | 81.73 | 107.44 | 85.77 | |
| EBIDT Annual margin % | 38.65 | 26.36 | 28.99 | 37.01 | 33.46 | |
| Depreciation | 10.90 | 10.28 | 9.56 | 8.93 | 8.81 | |
| PAT Before ExtraOrdinary Items Annual Cr | 108.12 | 55.53 | 54.51 | 71.01 | 57.95 | |
| Net Profit Annual | 108.12 | 55.53 | 54.51 | 71.01 | 57.95 | |
| Basic EPS Annual | 9.67 | 4.97 | 4.88 | 6.36 | 5.19 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 580.47 | 525.33 | 480.35 | 435.45 | 370.48 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 12.45 | 13.57 | 12.96 | 12.77 | 11.09 | |
| Total Current Liabilities Annual Cr | 40.01 | 36.90 | 36.31 | 41.04 | 41.10 | |
| Total Capital Plus Liabilities Annual Cr | 632.93 | 575.80 | 529.62 | 489.25 | 422.68 | |
| Fixed Assets Annual | 163.99 | 153.88 | 140.71 | 138.37 | 136.91 | |
| Total Non Current Assets Annual | 384.59 | 386.66 | 352.94 | 328.97 | 292.50 | |
| Total Current Assets Annual | 248.34 | 189.14 | 176.69 | 160.28 | 130.18 | |
| Total Assets Annual | 632.93 | 575.80 | 529.62 | 489.25 | 422.68 | |
| Contingent Liabilities plus Commitments Annual Cr | 17.73 | 13.69 | 8.64 | 11.60 | 16.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 55.81 | 50.30 | 37.10 | 84.19 | 45.98 | |
| Cash from Investing Activity Annual | -6.88 | -42.35 | -14.24 | -69.91 | -25.74 | |
| Cash from Financing Annual Activity | -56.88 | -11.99 | -10.87 | -15.45 | -17.75 | |
| Net Cash Flow Annual | -7.95 | -4.05 | 11.99 | -1.16 | 2.48 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 51.91 | 46.98 | 42.97 | 38.97 | 33.17 | |
| ROE Annual % | 18.62 | 10.56 | 11.34 | 16.30 | 15.64 | |
| ROCE Annual % | 25.82 | 13.80 | 14.62 | 21.97 | 20.16 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| EBDIT Annual Margin % | 44.87 | 27.18 | 29.95 | 37.90 | 34.67 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 167.31 | 175.33 | 163.94 | 153.95 | 149.79 | 150.63 | 142.56 | 123.12 | 135.12 | 134.76 | 127.98 | |
| Operating Expenses Qtr | 102.45 | 107.17 | 106.53 | 103.26 | 94.56 | 100.42 | 99.02 | 90.19 | 91.41 | 84.50 | 77.79 | |
| Operating Profit Qtr | 55.37 | 53.76 | 51.31 | 44.02 | 44.15 | 41.69 | 39.68 | 30.93 | 40.33 | 49.05 | 49.29 | |
| EBIDT Qtr Cr | 49.73 | 68.16 | 57.41 | 50.69 | 51.16 | 50.20 | 43.55 | 32.92 | 43.71 | 50.26 | 50.19 | |
| Depreciation Qtr | 9.28 | 8.60 | 8.73 | 8.63 | 8.45 | 9.13 | 8.81 | 8.64 | 9.08 | 8.82 | 8.60 | |
| Net Profit Qtr | 28.31 | 41.77 | 34.41 | 28.81 | 32.12 | 29.44 | 26.21 | 17.87 | 24.43 | 27.48 | 30.27 | |
| Basic EPS Qtr | 2.53 | 3.74 | 3.08 | 2.58 | 2.87 | 2.63 | 2.34 | 1.60 | 2.19 | 2.46 | 2.66 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 660.53 | 566.09 | 535.80 | 510.69 | 449.63 | |
| Operating Expenses Annual Cr | 419.41 | 384.19 | 327.97 | 270.31 | 241.66 | |
| Operating Profit Annual | 204.46 | 156.44 | 201.42 | 231.53 | 202.33 | |
| Operating Profit Margin Annual % | 30.95 | 27.64 | 37.59 | 45.34 | 45.00 | |
| Total Expenses Annual Cr | 457.58 | 421.64 | 364.75 | 300.32 | 270.47 | |
| EBIDT Annual Cr | 241.12 | 181.90 | 207.84 | 240.38 | 207.97 | |
| EBIDT Annual margin % | 36.50 | 32.13 | 38.79 | 47.07 | 46.25 | |
| Depreciation | 35.24 | 35.03 | 34.98 | 28.41 | 25.78 | |
| PAT Before ExtraOrdinary Items Annual Cr | 136.95 | 103.87 | 123.80 | 151.46 | 133.05 | |
| Net Profit Annual | 133.31 | 105.64 | 119.58 | 146.20 | 129.29 | |
| Basic EPS Annual | 11.92 | 9.45 | 10.68 | 13.07 | 11.56 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1324.13 | 1235.07 | 1088.59 | 970.66 | 839.65 | |
| Minority Interest Liability Annual Cr | 46.95 | 49.10 | 51.79 | 60.11 | 27.80 | |
| Total Non Current Liabilities Annual Cr | 58.03 | 60.11 | 66.80 | 54.35 | 46.13 | |
| Total Current Liabilities Annual Cr | 106.36 | 77.57 | 60.42 | 67.56 | 65.02 | |
| Total Capital Plus Liabilities Annual Cr | 1535.46 | 1421.85 | 1267.61 | 1152.67 | 978.61 | |
| Fixed Assets Annual | 365.55 | 349.70 | 338.11 | 321.10 | 278.88 | |
| Total Non Current Assets Annual | 725.72 | 699.74 | 663.17 | 636.61 | 598.22 | |
| Total Current Assets Annual | 809.74 | 722.11 | 604.44 | 516.07 | 380.39 | |
| Total Assets Annual | 1535.46 | 1421.85 | 1267.61 | 1152.67 | 978.61 | |
| Contingent Liabilities plus Commitments Annual Cr | 20.36 | 14.12 | 9.49 | 18.61 | 16.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 141.37 | 140.36 | 122.29 | 162.89 | 140.90 | |
| Cash from Investing Activity Annual | -64.65 | -298.18 | -24.91 | -26.03 | -44.50 | |
| Cash from Financing Annual Activity | -59.24 | -25.80 | -27.38 | -26.31 | -38.55 | |
| Net Cash Flow Annual | 17.48 | -183.62 | 70.00 | 110.55 | 57.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 122.61 | 114.84 | 102.00 | 92.25 | 77.67 | |
| ROE Annual % | 10.06 | 8.55 | 10.98 | 15.06 | 15.39 | |
| ROCE Annual % | 14.40 | 10.92 | 14.31 | 19.53 | 19.94 | |
| Total Debt to Total Equity Annual | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
| EBDIT Annual Margin % | 38.64 | 33.64 | 39.26 | 47.89 | 46.84 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC Small Cap Fund | 3.67 | 74540028 | - | - |
| ICICI Prudential ESG Fund | 1.77 | 74540029 | - | - |
| Nalanda India Equity Fund Limited | 8.91 | 74540035 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Kishor Laxminarayan Rathi | 1.31 | 74540011 | 0 | 0 |
| Madhusudan Kabra | 0.64 | 74540012 | 0 | 0 |
| Vasant Rathi | 33.14 | 74540021 | 0 | 0 |
| Rasika Vasant Rathi | 2.38 | 74540022 | 0 | 0 |
| Reshma Namita Rathi | 2.37 | 74540023 | 0 | 0 |
| Rachana Vasant Rathi | 2.36 | 74540024 | 0 | 0 |
| Prabhavati Vasant Rathi | 0.82 | 74540025 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC Small Cap Fund | 3.67 | 74540028 |
| ICICI Prudential ESG Fund | 1.77 | 74540029 |
| Orbimed Asia III Mauritius Limited | 9.88 | 74540034 |
| Nalanda India Equity Fund Limited | 8.91 | 74540035 |
| Clarus Capital I | 1.28 | 74540031 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Trusts | 0.69 | 74540038 |
| Pradip Bhailal Shah | 1.81 | 74540047 |
| Mukund Madhusudan Kabra | 1.63 | 74540053 |
| Orbimed Asia III Mauritius FVCI Limited | 2.2 | 74540049 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 18, 2024 | 1.1 | FINAL | Jul 18, 2024 | Equity Share |
| May 17, 2024 | 4 | INTERIM | May 18, 2024 | Equity Share |
| Aug 04, 2023 | 1 | FINAL | Aug 05, 2023 | Equity Share |
| May 19, 2023 | 4 | INTERIM | May 20, 2023 | Equity Share |
| Aug 11, 2022 | 1 | FINAL | Aug 12, 2022 | Equity Share |
| Aug 31, 2021 | 0.9 | FINAL | Sep 01, 2021 | Equity Share |
| Jul 09, 2020 | 0.6 | FINAL | - | Equity Share |
| Aug 01, 2019 | 0.6 | FINAL | - | Equity Share |
| Sep 06, 2018 | 0.5 | FINAL | - | Equity Share |
| Sep 04, 2017 | 0.4 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| May 25, 2017 | 10:2 | 2017-05-26 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 11, 2024 | Audited Results & Dividend | - |
| Feb 10, 2024 | Quarterly Results | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 12, 2023 | Quarterly Results | - |
| May 13, 2023 | Audited Results & Dividend | - |
| Feb 11, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 06, 2022 | Quarterly Results | - |
| May 20, 2022 | Audited Results & Final Dividend | - |
| Feb 05, 2022 | Quarterly Results | - |
| Nov 02, 2021 | Quarterly Results | - |
| Aug 07, 2021 | Quarterly Results | - |
| May 29, 2021 | Audited Results & Final Dividend | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Aug 12, 2020 | Quarterly Results | - |
| May 30, 2020 | Audited Results & Final Dividend | - |
| Feb 06, 2020 | Quarterly Results | - |
| Nov 02, 2019 | Quarterly Results | - |
| Aug 08, 2019 | Quarterly Results | - |
| May 24, 2019 | Audited Results & Final Dividend | - |
| Feb 09, 2019 | Quarterly Results | - |
| Nov 01, 2018 | Quarterly Results | - |
| Aug 11, 2018 | Quarterly Results | - |
| May 19, 2018 | Audited Results & Dividend | - |
| Feb 19, 2018 | Others | To consider and approve additional investment by way of subscription and/or acquisition of Shares of the Company's subsidiary, Advanced Enzymes (Malaysia) Sdn. Bhd. |
| Feb 06, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Sep 11, 2017 | Quarterly Results | - |
| Aug 09, 2017 | To consider raising of funds | inter alia, to consider and approve raising of funds of the company, by way of Qualified Institutional Placement route. (Revised) |
| Jul 01, 2017 | Others | To consider and approve incorporation of overseas subsidiary in Netherlands and Investment thereof. |
| May 27, 2017 | Audited Results & Dividend | - |
| Apr 22, 2017 | Others | Consider and approve investment proposals of the Company and incorporation of overseas subsidiaries. |
| Mar 25, 2017 | Others | Employees' Incentive Plan 2017 through trust route for the Company and its subsidiaries; and authorization to the said trust to acquire shares of the Company from the secondary Market. |
| Feb 14, 2017 | Quarterly Results & Stock Split | Sub-division of equity shares of the Company of face value of Rs. 10 each. |
| Nov 14, 2016 | Quarterly Results | - |
| Sep 15, 2016 | Resignation of Director | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 Jul 2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Revised Newspaper Publication - Navshakti , issue date July 03, 2024
02 Jul 2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication: NavShakti and Free Press Journal July 02, 2024
01 Jul 2024
Advanced Enzyme Technologies Ltd - 540025 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2023-24
01 Jul 2024
Advanced Enzyme Technologies Ltd - 540025 - Reg. 34 (1) Annual Report.
Integrated Annual Report for the Financial Year 2023-24
01 Jul 2024
Advanced Enzyme Technologies Ltd - 540025 - Notice Of 35Th Annual General Meeting Of The Company
Notice of 35th Annual General Meeting of the Company
28 Jun 2024
Advanced Enzyme Technologies Ltd - 540025 - Closure of Trading Window
Closure of Trading Window from July 01, 2024 till 48 hours after the announcement of financial results for the quarter ended June 30, 2024
27 Jun 2024
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News paper Publication - issue date June 27, 2024 - Navshakti and Free Press Journal , in relation to the 35th Annual General Meeting of the Company
25 Jun 2024
Advanced Enzyme Technologies Ltd - 540025 - Intimation Regarding Date Of Annual General Meeting ('AGM'), Record Date And Dividend Payment Date, If Approved At The AGM
Record Date has been fixed as Thursday, July 18, 2024, for the purpose of ascertaining the entitlement of the members to the Final Dividend for FY24 if approved (declared) at the 35th AGM
25 Jun 2024
Advanced Enzyme Technologies Ltd - 540025 - Intimation Regarding Date Of Annual General Meeting ('AGM'), Record Date And Dividend Payment Date, If Approved At The AGM
This is to inform that the 35th Annual General Meeting of the Company will be held on Thursday, July 25, 2024. Record Date has been fixed as Thursday July 18, 2024 for the purpose of ascertaining the entitlement of the members to the Final Dividend for FY24, if approved (declared) at the 35th AGM.
25 Jun 2024
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Bharat Pujara
